Search 11,116 records for:

Display

Collections

Format

Fulltext Search

Off On

Publication Type

Year

Topic

Show more

Name

Show more

Collection

Fulltext Search

Off On

Publication Type

Year

Topic

Show more

Name

Show more

Collection

OHSU 12 records found 1 - 10nextSearch took 0.17 seconds. 
1.
Identification of druggable mutations in Acute Myeloid Leukemia (AML), such as FLT3-ITD, has led to the development of targeted therapies capable of out-performing cytoto [...]
2022 | Abstract |
2.
This thesis describes fibroblast growth factor signaling in the development of resistance to tyrosine kinase inhibitor therapy in solid and hematologic malignancies, and [...]
2016-08-01 | Dissertation |
3.
Acute Myeloid Leukemia (AML) is an aggressive cancer with poor overall survival due to frequent relapse. FMS-like tyrosine kinase (FLT3) is the most commonly mutated gene [...]
2022 | Abstract |
4.
5.
6.
Gene transcription is fundamental in establishing and maintaining cell identity and function. All normal cells are encoded with the same DNA, so transcription is essentia [...]
2024-02-23 | Dissertation |
7.
November 2013 issue of the Scribe. Contents include clinical trials for acute myeloid leukemia treatment, care for senior patients, liability insurance, management of use [...]
2013-11 | Other | Medical Society of Metropolitan Portland records |
8.
This thesis is composed of two studies that utilizes different statistical methods to answer cancer research questions. The first study uses supervised and unsupervised s [...]
2023-09-13 | Dissertation |
9.
Leukemias comprise a family of hematologic malignancies characterized by the over-proliferation of myeloid precursor cells. Leukemia development depends on multiple facto [...]
2018-06-01 | Dissertation |
10.
Abnormal splicing events can promote drug resistance in a variety of cancer types, however, the full extent of genome-wide splicing in therapy-resistant AML is not fully [...]
2020 | Abstract |

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.